<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150128020854N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-09-30</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Effect of kegel exercise and lubricant gel on the sexual function</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of kegel exercise and lubricant gel on the sexual function of menopausal women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/40878</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: From the 7 health care centers in Dezful city, five centers will be randomly selected. Then postmenopausal women covered by these centers will be contacted and invited to participate in the study. Eligible women will be divided into three groups of 50 based on the random number table. In this way, all participants will be given three-digit codes from 001 to 150. Then, using the website www.Randomization.com, the statistical consultant will provide three sets of codes for researcher, the first in the intervention group with kegel, the second in the intervention group with lubricant gel, and the third in the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>sexual function.</hc_freetext>
      <i_freetext>Intervention 1: In the Kegel intervention group, in a 60-minute session, a brief introduction to the anatomy and function of the pelvic floor muscles, an introduction to how the Kegel exercise is performed, its mechanism and function, its benefits, and finally an evaluation of participants to ensure that the exercise is performed properly will be done. PowerPoint, replica pelvis and movies will be used through individually and face-to-face teaching. A daily checklist (three times daily in the morning, noon, night) for 12 weeks as well as a Kegel Exercise Training Guide will be given to the participants as a pamphlet and then weekly follow up by telephone is performed. Intervention 2: In the intervention group with lubricant gel 45 minutes training session will be held for familiarizing with pelvic  anatomy, pelvic floor muscles, vaginal and genitalia changes  in menopause, lubricant gel and its benefits and how to use it is performed and finally evaluation of participants for learning materials will be done. Participants will be asked to record the frequency of using lubricant gel in their checklists for 12 weeks and will be followed up weekly by phone for investigation any  reaction and side effects of lubricant gel and possible questions. Intervention 3: Control group: The control group will not receive any intervention and will solely receive general menopausal care. Demographic questionnaire and sexual function questionnaire will be completed with 12 weeks interval.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is All the data will be published in tables in the final paper.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Atefeh Khosravi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vali-Asr cross of Niyayesh</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>198571443</zip>
        <telephone>+98 61 3632 3587</telephone>
        <email>atefeh.khosravi120@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hedyeh Riazi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of nursing and midwifery, Valiasr ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>h.riazi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Physiologic menopause (not due to surgery or premature menopause before 40 years of age)
Being in the first 10 years of menopause
Lack of self-reported medical diseases affecting sexual function (respiratory and cardiovascular disease, arthritis, Parkinson's disease, or multiple sclerosis)
Lack of any self-reported psychological disease
Absence of depression, anxiety, or stress based on the Depression Anxiety Stress Scales (DAAS)
Scoring 2 or higher on the Oxford Grading Scale (OGS) for pelvic-floor muscle strength
having sexual function
Absence of impotence in the spouse (as declared by the participant)
Not taking any herbal medicine containing phytoestrogen or any form of hormone replacement therapy
Not taking any medicine affecting sexual function
Negative history of hysterectomy and mastectomy
Maximum five vaginal delivery
Lack of self-reported genital infections
Using lubricant gel in all  the sexual intercourses in lubricant gel intervention group)</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Unwillingness to cooperating in the study.
Allergy to lubricant gel.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F52.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unspecified sexual dysfunction not due to a substance or known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the Kegel intervention group, in a 60-minute session, a brief introduction to the anatomy and function of the pelvic floor muscles, an introduction to how the Kegel exercise is performed, its mechanism and function, its benefits, and finally an evaluation of participants to ensure that the exercise is performed properly will be done. PowerPoint, replica pelvis and movies will be used through individually and face-to-face teaching. A daily checklist (three times daily in the morning, noon, night) for 12 weeks as well as a Kegel Exercise Training Guide will be given to the participants as a pamphlet and then weekly follow up by telephone is performed.</i_keyword>
      <i_keyword>In the intervention group with lubricant gel 45 minutes training session will be held for familiarizing with pelvic  anatomy, pelvic floor muscles, vaginal and genitalia changes  in menopause, lubricant gel and its benefits and how to use it is performed and finally evaluation of participants for learning materials will be done. Participants will be asked to record the frequency of using lubricant gel in their checklists for 12 weeks and will be followed up weekly by phone for investigation any  reaction and side effects of lubricant gel and possible questions.</i_keyword>
      <i_keyword>Control group: The control group will not receive any intervention and will solely receive general menopausal care. Demographic questionnaire and sexual function questionnaire will be completed with 12 weeks interval.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sexual function. Timepoint: Before intervention, one, two and three months after intervention. Method of measurement: ّFemale Sexual function questionnaire (FSFI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-07-18</approval_date>
        <contact_name>Shahid Beheshti Univercity of Medical Sciences, School of Nursing and Midwifery</contact_name>
        <contact_address>Vali Asr Ave, Niayesh Cross Road, SBMU School of Nursing &amp; Midwifery Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
